Compare · RELX vs RFL
RELX vs RFL
Side-by-side comparison of RELX PLC PLC (RELX) and Rafael Holdings Inc. (RFL): market cap, price performance, sector, and recent activity on the wire.
Summary
- RELX operates in Real Estate, while RFL operates in Finance - the two are in different parts of the market.
- RELX is the larger of the two at $64.11B, about 795.3x RFL ($80.6M).
- RELX has hit the wire 3 times in the past 4 weeks while RFL has been quiet.
- RELX has more recent analyst coverage (12 ratings vs 0 for RFL).
- Company
- RELX PLC PLC
- Rafael Holdings Inc.
- Price
- $34.52-1.78%
- $1.63+5.16%
- Market cap
- $64.11B
- $80.6M
- 1M return
- +1.07%
- -
- 1Y return
- -34.93%
- -
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NYSE
- IPO
- 2015
- 2018
- News (4w)
- 3
- 0
- Recent ratings
- 12
- 0
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Rafael Holdings Inc.
Rafael Holdings, Inc. owns commercial real estate assets and interests in pre-clinical and clinical stage pharmaceutical companies. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Latest RELX
- Goldman initiated coverage on RELX
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- Consumers Ready and Comfortable to Share their Medical Information Electronically for Easier Life Insurance Underwriting
- RELX downgraded by Morgan Stanley
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- WEPACK 2026 Concludes on a Record High, Reinforcing China's Role at the Heart of the Global Packaging Industry
- SEC Form 6-K filed by RELX PLC PLC
- Cytora and LexisNexis Risk Solutions announce strategic relationship to enhance risk selection and automation for U.S. commercial insurers
Latest RFL
- Rafael Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Rafael Holdings Announces Patent Licensing Agreement with MIT for "Small Molecules to Improve Myelination in ApoE4 positive Alzheimer's Disease"
- SEC Form 4 filed by Polinsky David
- Exec Chairman, CEO & President Jonas Howard S covered exercise/tax liability with 9,826 units of Class B Common Stock, decreasing direct ownership by 3% to 323,014 units (SEC Form 4)
- SEC Form 10-Q filed by Rafael Holdings Inc.
- Rafael Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results
- Director Sieger Markus was granted 29,528 units of Class B Common Stock, increasing direct ownership by 16% to 219,710 units (SEC Form 4)
- Director Weiss Michael J was granted 39,370 units of Class B Common Stock, increasing direct ownership by 38% to 141,861 units (SEC Form 4)
- Director Stein Mark N was granted 39,370 units of Class B Common Stock, increasing direct ownership by 343% to 50,845 units (SEC Form 4)